ALKEM LABORATORIES
Back to Cashflow Statement
|
ALKEM LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-811 Cr | ₹-1,145 Cr | ₹-1,761 Cr | ₹380 Cr | ₹-272 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALKEM LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-811 Cr |
| Mar2024 | ₹-1,145 Cr |
| Mar2023 | ₹-1,761 Cr |
| Mar2022 | ₹380 Cr |
| Mar2021 | ₹-272 Cr |
How is Cash Flow from Financing Activities of ALKEM LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-811 Cr | Negative | |
| Mar2024 | ₹-1,145 Cr | Negative | |
| Mar2023 | ₹-1,761 Cr | Negative | |
| Mar2022 | ₹380 Cr | Positive | |
| Mar2021 | ₹-272 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹68,823.2 Cr | 0.6% | 3.4% | 11% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | 1.7% | -5.7% | -7.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | 0.8% | -6.7% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | 0.6% | 4.3% | 24.4% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -4.7% | -12.3% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 6.3% | -2.1% | -4.1% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 0.6% |
3.4% |
11% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses